This technology is a programmable, multiplexed serodiagnostic method that detects SARS-CoV-2 specific epitopes and differentiates these from other human coronavirus epitopes, allowing for precise diagnosis of SARS-CoV-2 exposure.
This technology is a multiplex, array-based serologic assay for the rapid diagnosis of tick-borne illnesses, adaptable to other formats such as a lateral flow device.
This technology is a rapid, highly sensitive multiplex qPCR one step assay that enables differential diagnosis of arboviruses, including Zika, Dengue, Chikungunya, and West Nile viruses.
